Alfresa Holdings Corp (2784):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alfresa Holdings Corp (2784) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3425
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alfresa Holdings Corp (Alfresa) is a manufacturer and marketer of pharmaceuticals, diagnostic reagent and medical devices. The company offers ethical pharmaceuticals wholesaling, self-medication products and manufacturing. It’s ethical pharmaceutical wholesaling business supplies diagnostic reagents, medical devices and equipment to hospitals, clinics, dispensing pharmacies and other institutions. Alfresa’s self-medication products wholesaling business offer health foods, supplements, cosmetics, and other products to drugstores and pharmacies. The company offers comprehensive healthcare services by broadening its operational scale and scope. It markets its products in Japan and abroad. Alfresa is headquartered in Chiyoda-Ku, Tokyo, Japan.

Alfresa Holdings Corp (2784) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfresa Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Alfresa Pharma to Acquire 41 Products from Daiichi Sankyo 12
Partnerships 13
Sanofi Enters Into Co-Development Agreement With Alfresa For Antiepileptic Drug 13
Acquisition 14
Alfresa to Acquire Sannova from Eisai 14
Alfresa Completes Acquisition Of Tokiwa Yakuhin 15
Alfresa Acquires Remaining 48.98% Stake In Kowa Pharma 17
Alfresa Holdings Corp – Key Competitors 18
Alfresa Holdings Corp – Key Employees 19
Alfresa Holdings Corp – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Corporate Communications 22
Dec 21, 2017: Alfresa Announces Appointment and Resignation for Representative Directors 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfresa Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfresa Holdings Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Alfresa Pharma to Acquire 41 Products from Daiichi Sankyo 12
Sanofi Enters Into Co-Development Agreement With Alfresa For Antiepileptic Drug 13
Alfresa to Acquire Sannova from Eisai 14
Alfresa Completes Acquisition Of Tokiwa Yakuhin 15
Alfresa Acquires Remaining 48.98% Stake In Kowa Pharma 17
Alfresa Holdings Corp, Key Competitors 18
Alfresa Holdings Corp, Key Employees 19
Alfresa Holdings Corp, Subsidiaries 20

List of Figures
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alfresa Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alfresa Holdings Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Alfresa Holdings Corp (2784):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Steelcase Inc (SCS):企業の財務・戦略的SWOT分析
    Steelcase Inc (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Turner Broadcasting System Inc:企業の戦略的SWOT分析
    Turner Broadcasting System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Fortune Brands Home & Security Inc:企業の戦略・SWOT・財務情報
    Fortune Brands Home & Security Inc - Strategy, SWOT and Corporate Finance Report Summary Fortune Brands Home & Security Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Royal BAM Group nv:戦略・SWOT・企業財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • OctreoPharm Sciences GmbH-医療機器分野:企業M&A・提携分析
    Summary OctreoPharm Sciences GmbH (OPS), a subsidiary of Ipsen SA is a clinical development biopharmaceutical company that develops radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company develops theranostic couple of antagonistic peptides for the diagnosis and treatme …
  • Brigham and Women’s Hospital:企業のM&A・事業提携・投資動向
    Brigham and Women's Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brigham and Women's Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Taiga Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Taiga Biotechnologies Inc (Taiga Biotech) is a biopharmaceutical company that develops protein and cellular therapies. The company develops therapies for diseases including cancers and infectious diseases. It provides pipeline products such as programs such as stem cell therapy and target sp …
  • Trovagene Inc (TROV)-医療機器分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • Sheridan Healthcare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sheridan Healthcare Inc (Sheridan Healthcare), a subsidiary of AmSurg Corp, is a healthcare service provider that offers physician services. The center offers office-based services in the areas of OBGYN, gynecology, gynecologic oncology, perinatology and pain management. It provides support, …
  • China Sunergy Co., Ltd. (CSUN):企業の財務・戦略的SWOT分析
    China Sunergy Co., Ltd. (CSUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Pack Corporation
    The Pack Corporation - Strategy, SWOT and Corporate Finance Report Summary The Pack Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intezyne Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intezyne Inc (Intezyne) is a biotechnology company that develops product candidates for the treatment of various cancer tumors. The company offers anti-cancer agents and IVECT method to improve cancer therapy. It provides compounds that are cellular or molecularly targeted or have tumor-spec …
  • Norwegian Air Shuttle ASA:企業の戦略・SWOT・財務情報
    Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report Summary Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Stater Bros. Markets:企業の戦略・SWOT・財務情報
    Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report Summary Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gedeon Richter Plc:企業の戦略・SWOT・財務情報
    Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report Summary Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Spark New Zealand Ltd:企業の戦略・SWOT・財務分析
    Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report Summary Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eurofins MWG Operon LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins MWG Operon LLC (Eurofins) is a DNA sequencing service provider. The company offers DNA sequencing services, DNA synthesis products, and bioinformatic services. Its product categories comprise DNA and RNA synthesis, DNA sequencing, GENE synthesis and next gen seq. Eurofins provides n …
  • AusNet Services Ltd (AST):企業の財務・戦略的SWOT分析
    AusNet Services Ltd (AST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆